Dr. Lubeck owns Genentech stock. Mr. Cornelio and Dr. Chiou own Amgen stock.
Development and validation of the revised Cedars-Sinai health-related quality of life for rheumatoid arthritis instrument
Article first published online: 30 NOV 2006
Copyright © 2006 by the American College of Rheumatology
Arthritis Care & Research
Volume 55, Issue 6, pages 856–863, 15 December 2006
How to Cite
Chiou, C. F., Sherbourne, C. D., Cornelio, I., Lubeck, D. P., Paulus, H. E., Dylan, M., Chang, C. H. and Weisman, M. H. (2006), Development and validation of the revised Cedars-Sinai health-related quality of life for rheumatoid arthritis instrument. Arthritis & Rheumatism, 55: 856–863. doi: 10.1002/art.22090
- Issue published online: 30 NOV 2006
- Article first published online: 30 NOV 2006
- Manuscript Accepted: 1 AUG 2006
- Manuscript Received: 9 SEP 2004
- Amgen Inc., Thousand Oaks, California
|jws-art.22090.pdf||273K||The Expanded Cedars-Sinai Health-Related Quality of Life Instrument (CSHQ-RA)|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.